1. Home
  2. LEE vs LEXX Comparison

LEE vs LEXX Comparison

Compare LEE & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEE
  • LEXX
  • Stock Information
  • Founded
  • LEE 1890
  • LEXX 2004
  • Country
  • LEE United States
  • LEXX Canada
  • Employees
  • LEE N/A
  • LEXX N/A
  • Industry
  • LEE Newspapers/Magazines
  • LEXX Biotechnology: Pharmaceutical Preparations
  • Sector
  • LEE Consumer Discretionary
  • LEXX Health Care
  • Exchange
  • LEE Nasdaq
  • LEXX Nasdaq
  • Market Cap
  • LEE 53.9M
  • LEXX 49.3M
  • IPO Year
  • LEE N/A
  • LEXX N/A
  • Fundamental
  • Price
  • LEE $9.01
  • LEXX $3.31
  • Analyst Decision
  • LEE
  • LEXX Strong Buy
  • Analyst Count
  • LEE 0
  • LEXX 2
  • Target Price
  • LEE N/A
  • LEXX $11.00
  • AVG Volume (30 Days)
  • LEE 14.5K
  • LEXX 99.1K
  • Earning Date
  • LEE 08-01-2024
  • LEXX 11-18-2024
  • Dividend Yield
  • LEE N/A
  • LEXX N/A
  • EPS Growth
  • LEE N/A
  • LEXX N/A
  • EPS
  • LEE N/A
  • LEXX N/A
  • Revenue
  • LEE $616,815,000.00
  • LEXX $411,019.00
  • Revenue This Year
  • LEE N/A
  • LEXX $82.02
  • Revenue Next Year
  • LEE N/A
  • LEXX $95.09
  • P/E Ratio
  • LEE N/A
  • LEXX N/A
  • Revenue Growth
  • LEE N/A
  • LEXX 34.05
  • 52 Week Low
  • LEE $7.56
  • LEXX $0.85
  • 52 Week High
  • LEE $15.89
  • LEXX $6.85
  • Technical
  • Relative Strength Index (RSI)
  • LEE 56.22
  • LEXX 53.27
  • Support Level
  • LEE $8.54
  • LEXX $2.91
  • Resistance Level
  • LEE $9.32
  • LEXX $3.19
  • Average True Range (ATR)
  • LEE 0.35
  • LEXX 0.21
  • MACD
  • LEE 0.12
  • LEXX 0.00
  • Stochastic Oscillator
  • LEE 71.64
  • LEXX 71.43

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high quality, trusted, intensely local news, information, advertising and marketing services. Its product portfolio includes digital subscription platforms, daily, weekly and monthly newspapers and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and its content and advertising is available in real time through the websites and mobile apps.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH has the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. The Company has four reportable segments: Intellectual Property Licensing, B2B Production, Research and Development and Corporate. It earns maximum revenue from Intellectual Property Licensing.

Share on Social Networks: